Clinic
Altamed Health Services Corporation
Altamed Health Services Corporation was paid $1.50M by Medicaid between Jan 2018 and Oct 2024, across 262 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 17% of everything it billed.
33Billing provider infoALTAMED HEALTH SERVICES CORPORATION
LOS ANGELES, CA 90040
LOS ANGELES, CA 90040
33aNPI1073744710assigned 07/29/2009
33bProvider typeCorporate Health Clinic/Center
28Total paid$1.50M
24GClaims278,452
24DCodes billed262
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Corporate Health Clinic/Center providers in California
Rank by total paid#2 of 6
Median peer was paid$25K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 244 | $295.54 | |
| 2019 | 18,995 | $50K | |
| 2020 | 76,758 | $343K | |
| 2021 | 95,613 | $749K | |
| 2022 | 6,860 | $15K | |
| 2023 | 5,098 | $222K | |
| 2024incomplete | 74,884 | $115K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 17% | 3,218 | 704 | $256K |
| G9012 | Other specified case management service not elsewhere classified | 17% | 7,840 | 2,716 | $254K |
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 8.7% | 558 | 50 | $130K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.3% | 20,785 | 18,790 | $109K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 1,854 | 1,707 | $67K |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 3.0% | 35,116 | 13,996 | $45K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.5% | 4,140 | 4,086 | $37K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.5% | 4,132 | 4,078 | $37K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 1.7% | 1,018 | 991 | $26K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | 1.4% | 615 | 610 | $21K |
| 80053 | Comprehensive metabolic panel | 1.4% | 9,620 | 8,980 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 1,075 | 398 | $20K |
250 more codes
| D1120 | Dental cleaning, child | 1.3% | 630 | $19K |
| 80061 | Lipid panel | 1.2% | 6,932 | $19K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 4,760 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 5,634 | $17K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.1% | 772 | $16K |
| D1206 | Topical application of fluoride varnish | 1.0% | 736 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,388 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,782 | $12K |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 1,286 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,130 | $12K |
| B9002 | Enteral nutrition infusion pump, any type | <1% | 160 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,400 | $12K |
| 99199 | Unlisted special service, procedure or report | <1% | 661 | $11K |
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | <1% | 373 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,192 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 351 | $8K |
| D1310 | <1% | 725 | $8K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 210 | $8K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 343 | $7K |
| 86003 | <1% | 138 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 321 | $7K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 948 | $7K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,201 | $6K |
| D9999 | Unspecified adjunctive procedure, by report | <1% | 203 | $6K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 104 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 267 | $5K |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 425 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 32 | $5K |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 294 | $5K |
| E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | <1% | 903 | $5K |
| 86803 | <1% | 1,108 | $4K | |
| 97014 | <1% | 381 | $4K | |
| T4534 | Youth sized disposable incontinence product, protective underwear/pull-on, each | <1% | 167 | $4K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 551 | $4K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 355 | $4K |
| B9998 | Noc for enteral supplies | <1% | 348 | $4K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | <1% | 183 | $4K |
| T4530 | Pediatric sized disposable incontinence product, brief/diaper, large size, each | <1% | 186 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,429 | $3K |
| D0603 | <1% | 614 | $3K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 533 | $3K |
| 80081 | <1% | 311 | $3K | |
| 97010 | <1% | 1,230 | $3K | |
| 76641 | <1% | 35 | $3K | |
| D0120 | Dental checkup, returning patient | <1% | 241 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 814 | $2K |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | <1% | 16 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 50 | $2K |
| 82274 | <1% | 769 | $2K | |
| 86480 | <1% | 241 | $2K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 49 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 411 | $2K |
| 87088 | <1% | 1,722 | $2K | |
| 82652 | <1% | 345 | $2K | |
| K0001 | Standard wheelchair | <1% | 224 | $2K |
| E0443 | Portable oxygen contents, gaseous, 1 month's supply = 1 unit | <1% | 53 | $2K |
| A4335 | Incontinence supply; miscellaneous | <1% | 404 | $2K |
| 86592 | <1% | 2,499 | $2K | |
| 82728 | <1% | 678 | $2K | |
| 81001 | <1% | 3,084 | $2K | |
| 84439 | <1% | 1,160 | $2K | |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 445 | $2K |
| 59425 | <1% | 84 | $2K | |
| 84460 | <1% | 533 | $2K | |
| 82607 | <1% | 661 | $2K | |
| 83615 | <1% | 458 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 223 | $2K |
| 87510 | <1% | 437 | $2K | |
| 80074 | <1% | 247 | $2K | |
| 90686 | <1% | 784 | $2K | |
| 87480 | <1% | 434 | $2K | |
| 87660 | <1% | 434 | $2K | |
| 80305 | <1% | 134 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 36 | $2K |
| V2020 | Frames, purchases | <1% | 76 | $2K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 36 | $2K |
| 92015 | Determination of refractive state | <1% | 427 | $1K |
| 84450 | <1% | 433 | $1K | |
| 85027 | <1% | 1,450 | $1K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 58 | $1K |
| 82570 | <1% | 1,647 | $1K | |
| 76813 | <1% | 26 | $1K | |
| 83970 | <1% | 81 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 99 | $1K |
| 82043 | <1% | 1,471 | $1K | |
| 82746 | <1% | 475 | $1K | |
| E0776 | Iv pole | <1% | 131 | $1K |
| 84403 | <1% | 168 | $1K | |
| 81329 | <1% | 149 | $1K | |
| 99173 | <1% | 196 | $1K | |
| 87186 | <1% | 607 | $1K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 24 | $1K |
| 87340 | <1% | 504 | $1K | |
| 83013 | <1% | 41 | $1K | |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | <1% | 63 | $1K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 46 | $1K |
| 99283 | Emergency room visit (moderate) | <1% | 12 | $1K |
| 84702 | <1% | 393 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 14 | $1K |
| 84153 | <1% | 366 | $1K | |
| 83001 | <1% | 241 | $997.17 | |
| 83540 | <1% | 662 | $974.97 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 1,781 | $923.52 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 641 | $917.17 |
| 93000 | <1% | 46 | $893.55 | |
| 84146 | <1% | 160 | $886.72 | |
| 86038 | <1% | 398 | $883.59 | |
| 92060 | <1% | 155 | $881.21 | |
| 87077 | <1% | 582 | $844.19 | |
| 83002 | <1% | 192 | $784.93 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $767.40 |
| 84481 | <1% | 174 | $764.48 | |
| 84436 | <1% | 502 | $747.68 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 144 | $711.41 |
| 83550 | <1% | 546 | $691.67 | |
| 82785 | <1% | 111 | $684.32 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 524 | $677.00 |
| 87070 | <1% | 319 | $661.36 | |
| G9920 | Screening performed and negative | <1% | 43 | $609.00 |
| 80076 | <1% | 298 | $542.56 | |
| 83735 | <1% | 344 | $536.83 | |
| 86140 | <1% | 614 | $503.96 | |
| 86900 | <1% | 111 | $488.10 | |
| 84479 | <1% | 343 | $479.66 | |
| 85060 | <1% | 144 | $467.31 | |
| 90674 | <1% | 14 | $456.26 | |
| 83655 | <1% | 95 | $437.50 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | <1% | 252 | $414.84 |
| 92134 | <1% | 14 | $411.23 | |
| 84550 | <1% | 494 | $411.20 | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 17 | $402.56 |
| 97116 | <1% | 39 | $400.44 | |
| 86706 | <1% | 257 | $384.40 | |
| 85018 | <1% | 414 | $381.15 | |
| 85610 | <1% | 531 | $380.60 | |
| 86704 | <1% | 143 | $366.32 | |
| 85730 | <1% | 362 | $334.40 | |
| 97161 | <1% | 13 | $313.56 | |
| 81002 | <1% | 432 | $308.90 | |
| 85652 | <1% | 700 | $307.78 | |
| 88141 | <1% | 109 | $305.37 | |
| 86431 | <1% | 270 | $303.51 | |
| 92551 | <1% | 181 | $300.51 | |
| 82950 | <1% | 436 | $300.51 | |
| 86787 | <1% | 58 | $289.48 | |
| 87150 | <1% | 33 | $276.60 | |
| 87338 | <1% | 143 | $232.71 | |
| 82670 | <1% | 26 | $223.50 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 101 | $218.54 |
| 81003 | <1% | 585 | $217.50 | |
| 84480 | <1% | 83 | $207.89 | |
| 87081 | <1% | 291 | $204.31 | |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | <1% | 188 | $201.60 |
| 82248 | <1% | 217 | $168.77 | |
| 96127 | <1% | 130 | $168.35 | |
| 86376 | <1% | 26 | $151.32 | |
| 84156 | <1% | 168 | $149.19 | |
| 86708 | <1% | 111 | $148.65 | |
| 82951 | <1% | 29 | $144.06 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 44 | $143.20 |
| 84100 | <1% | 226 | $140.49 | |
| 86317 | <1% | 13 | $131.89 | |
| 86200 | <1% | 77 | $127.80 | |
| 86762 | <1% | 13 | $126.61 | |
| 87147 | <1% | 141 | $125.12 | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 12 | $115.00 |
| 85007 | <1% | 247 | $110.39 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 34 | $110.00 |
| 81025 | <1% | 68 | $87.14 | |
| D0274 | Bitewings - four radiographic images | <1% | 51 | $75.60 |
| A4450 | Tape, non-waterproof, per 18 square inches | <1% | 46 | $71.72 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 67 | $70.38 |
| D9430 | <1% | 132 | $66.00 | |
| 85014 | <1% | 40 | $58.59 | |
| 83690 | <1% | 95 | $53.74 | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 102 | $50.92 |
| 86780 | <1% | 13 | $50.16 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 203 | $49.50 |
| 82952 | <1% | 13 | $40.69 | |
| 82947 | <1% | 13 | $37.68 | |
| 81015 | <1% | 56 | $36.60 | |
| A4649 | Surgical supply; miscellaneous | <1% | 15 | $34.30 |
| 87205 | <1% | 40 | $30.89 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 42 | $30.23 |
| D0270 | <1% | 13 | $30.00 | |
| 82962 | <1% | 15 | $23.55 | |
| 84703 | <1% | 12 | $17.76 | |
| D0350 | <1% | 354 | $13.20 | |
| 82565 | <1% | 13 | $12.27 | |
| D0272 | Bitewings - two radiographic images | <1% | 12 | $11.00 |
| 99000 | <1% | 380 | $10.77 | |
| 86593 | <1% | 14 | $10.40 | |
| D0210 | Intraoral - complete series of radiographic images | <1% | 13 | $9.00 |
| 81000 | <1% | 52 | $7.80 | |
| 3008F | <1% | 2,062 | $7.33 | |
| 86901 | <1% | 13 | $5.83 | |
| 3074F | <1% | 646 | $4.67 | |
| 3078F | <1% | 510 | $4.34 | |
| 83721 | <1% | 29 | $1.64 | |
| 3079F | <1% | 70 | $0.30 | |
| 0502F | <1% | 251 | $0.15 | |
| 3725F | <1% | 59 | $0.14 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 25 | $0.00 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 0% | 1,211 | $0.00 |
| D9993 | 0% | 1,145 | $0.00 | |
| 82948 | 0% | 13 | $0.00 | |
| 99072 | 0% | 123 | $0.00 | |
| T1001 | Nursing assessment / evaluation | 0% | 89 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 169 | $0.00 |
| T4528 | Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each | 0% | 108 | $0.00 |
| T1003 | Lpn/lvn services, up to 15 minutes | 0% | 89 | $0.00 |
| 97803 | 0% | 72 | $0.00 | |
| 86318 | 0% | 443 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 41 | $0.00 |
| 97164 | 0% | 45 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 14 | $0.00 |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | 0% | 12 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 130 | $0.00 |
| 1160F | 0% | 30 | $0.00 | |
| 90836 | 0% | 58 | $0.00 | |
| 86039 | 0% | 12 | $0.00 | |
| 90837 | Psychotherapy session, about an hour | 0% | 15 | $0.00 |
| 0002A | 0% | 26 | $0.00 | |
| 3351F | 0% | 2,294 | $0.00 | |
| D0999 | Unspecified diagnostic procedure, by report | 0% | 199 | $0.00 |
| D1330 | 0% | 697 | $0.00 | |
| 1126F | 0% | 16 | $0.00 | |
| 99441 | 0% | 1,766 | $0.00 | |
| T1016 | Case management, each 15 minutes | 0% | 1,459 | $0.00 |
| D9995 | 0% | 553 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 0% | 356 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 779 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 106 | $0.00 |
| 97165 | 0% | 17 | $0.00 | |
| S9977 | Meals, per diem, not otherwise specified | 0% | 65,473 | $0.00 |
| 0515 | 0% | 101 | $0.00 | |
| 91301 | 0% | 59 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 120 | $0.00 |
| 0012A | 0% | 88 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 16 | $0.00 |
| B4150 | Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | 0% | 91 | $0.00 |
| T1002 | Rn services, up to 15 minutes | 0% | 37 | $0.00 |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 0% | 27 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 0% | 372 | $0.00 |
| 97018 | 0% | 54 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 0011A | 0% | 72 | $0.00 | |
| 0001A | 0% | 34 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 31 | $0.00 |
| 3075F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Altamed Health Services Corp. | Los Angeles, CA | $305.80M |
| Altamed Health Services Corp | West Covina, CA | $83.90M |
| Altamed Health Services Corp | Pico Rivera, CA | $70.97M |
| Altamed Health Services Corp | El Monte, CA | $56.32M |
| Altamed Health Services Corp | Huntington Beach, CA | $53.30M |
| Altamed Health Services Corp | Los Angeles, CA | $50.84M |
| Altamed Health Services Corp | Santa Ana, CA | $43.62M |
| Altamed Health Services Corp | Santa Ana, CA | $40.31M |
| Altamed Health Services Corp | E. Los Angeles, CA | $33.24M |
| Altamed Health Services Corp | Garden Grove, CA | $30.84M |
| Altamed Health Services Corp | Los Angeles, CA | $23.94M |
| Altamed Health Services Corp | Orange, CA | $19.54M |
| Altamed Health Services Corp | Pico Rivera, CA | $14.32M |
| Altamed Health Services Corp | Anaheim, CA | $7.95M |
| Robert L. Young, JR. , DDS | Charlotte, NC | $7.89M |
| Altamed Health Services Corp | Los Angeles, CA | $3.75M |
| Altamed Health Services Corp | Anaheim, CA | $3.62M |
| Altamed Health Services Corp | Anaheim, CA | $3.60M |
| Robert L Young 2 DDS PA | Mint Hill, NC | $2.39M |
| Altamed Health Services Corp | Los Angeles, CA | $2.03M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.